Bowhead Specialty Holdings Inc. filings document the regulatory record of a specialty property and casualty insurance company with casualty, professional liability and healthcare liability products. Its 8-K filings cover operating results, investor presentations, material agreements, reinsurance arrangements involving Bowhead Insurance Company, Bowhead Underwriting Services and American Family, and capital-structure actions.
The company’s SEC record also includes proxy materials for annual stockholder voting and governance matters, board and committee changes, a senior revolving credit agreement, registered senior notes due 2030, and common-stock offering disclosures involving a selling stockholder. The filings identify Bowhead as an emerging growth company and provide formal disclosure on financing terms, underwriting agreements, risk allocation and public-company governance.
Bowhead Specialty Holdings CEO Stephen J. Sills reported bona fide gifts of 255,400 shares of common stock on March 12–13. These G-code transactions reflect gift transfers from his direct holdings and several family trusts and GRATs. After these gifts, he holds 832,150 shares directly, along with multiple indirect trust and entity positions disclosed as of those dates.
Bowhead Specialty Holdings Inc. files its annual report describing a fast-growing specialty property and casualty insurer focused on complex commercial risks. Gross written premiums reached $862.8 million for the year ended December 31, 2025, up from $695.7 million in 2024 and $507.7 million in 2023.
The business is concentrated in Casualty lines, which generated $550.7 million of 2025 premiums, alongside Professional Liability, Healthcare Liability and the newer Baleen Specialty unit. Bowhead mainly writes excess and surplus lines through a craft model for large, complex risks and a digital model for smaller accounts.
The company relies on a strategic partnership with American Family Mutual Insurance Company, which issues policies and cedes 100% of business to Bowhead’s insurance subsidiary in exchange for a ceding fee. A conservative balance sheet, extensive reinsurance program, and investment-grade fixed income portfolio support its underwriting-first strategy and expansion across U.S. specialty markets.
Bowhead Specialty Holdings reported strong growth for the quarter and year ended December 31, 2025. Fourth-quarter gross written premiums rose 21.3% to $224.1 million, with net income of $14.8 million, or $0.44 per diluted share, and a combined ratio of 96.9%.
For full-year 2025, gross written premiums increased 24.0% to $862.8 million and net income grew 40.6% to $53.8 million, or $1.59 per diluted share. Adjusted net income was $55.6 million, or $1.65 per diluted share, with a 13.6% adjusted return on equity and a 96.5% combined ratio. Management highlighted rapid expansion of the Baleen digital platform and reiterated expectations for around 20% gross written premium growth in 2026, led by the Casualty division.
Bowhead Specialty Holdings Inc. CFO and Treasurer Brad Mulcahey reported equity compensation and related tax-withholding transactions in the company’s common stock.
On February 19, 2026, he acquired 25,145 shares through a grant of restricted stock units. On February 20, 2026, he disposed of 1,274 shares, surrendered to the issuer to cover required tax withholdings upon RSU vesting at $24.90 per share. Following these transactions, he directly owned 136,327 common shares.
Bowhead Specialty Holdings Inc. Chief Underwriting Officer David John Newman reported two equity-related transactions in common stock. On February 19, 2026, he acquired 23,488 shares at a stated price of $0.00 per share as a grant of restricted stock units. On February 20, 2026, he disposed of 1,443 shares at $24.90 per share, surrendering them back to the company to cover required tax withholdings upon vesting. After these transactions, he directly held just under 300,000 shares.
Bowhead Specialty Holdings Inc. CEO and President Stephen Jay Sills reported equity compensation grants and related tax withholding activity in Common Stock. On February 19, he received two stock awards totaling 90,703 and 88,566 shares, recorded as grant or award acquisitions at no cash cost.
On February 20, 5,419 shares were surrendered to the issuer to cover required tax withholdings due upon vesting of restricted stock units at $24.90 per share, a tax-withholding disposition rather than an open-market sale. He also reports additional indirect holdings through various family trusts and entities.
Bowhead Specialty Holdings Inc. Chief Accounting Officer Shirley Shek Li Yap reported two stock-based compensation entries involving the company’s common stock. On February 19, 2026, she acquired 9,826 shares through a grant of restricted stock units at a stated price of $0.0000 per share, as noted in a footnote explaining it reflects an RSU grant. On February 20, 2026, she disposed of 524 shares at $24.90 per share to satisfy required tax withholdings upon vesting of restricted stock units, with a footnote clarifying these shares were surrendered to the issuer for tax purposes rather than sold in the open market.
Bowhead Specialty Holdings Inc. received a Schedule 13G reporting that American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research beneficially own 1,827,525 shares of Bowhead common stock, representing 5.6% of the class as of December 31, 2025.
The filing shows sole voting power over 1,625,459 shares and sole dispositive power over 1,827,525 shares. The securities are reported as being held in the ordinary course of business, not for the purpose of changing or influencing control of Bowhead.
Bowhead Specialty Holdings Inc. director reported acquiring additional common stock in the company. On May 1, 2025, the reporting person acquired 4,038 shares of common stock at a stated price of $0, bringing their directly held beneficial ownership to 36,773 shares after the transaction.
The footnotes explain that this total includes 23,324 shares of common stock that were previously received on September 19, 2024 for no consideration, as part of a pro rata distribution connected to the dissolution of Bowhead Insurance Holdings LP. That earlier acquisition was treated as exempt from reporting under Rule 16a-9 of the Securities Exchange Act of 1934.
Bowhead Specialty Holdings Inc. entered into a new senior secured revolving credit facility of $35 million with a syndicate of lenders and PNC Bank as administrative agent, effective November 26, 2025. The facility allows the company to borrow, issue letters of credit and obtain swing line loans for general corporate purposes, including funding growth, working capital, capital expenditures and refinancing debt, and initially had no borrowings outstanding on the effective date.
The revolving credit facility matures on the earlier of November 26, 2027 or a date tied to the potential termination of certain MGA agreements, and is secured by a first-priority lien on substantially all of the company’s assets. Borrowings will bear interest at either a Term SOFR-based rate plus a 1.75% margin or an alternate base rate plus a 0.75% margin, with additional fees on unused commitments and letters of credit. The agreement includes customary covenants and financial tests, including a maximum total debt of 35% of total capitalization, minimum insurance subsidiary capital requirements, and a minimum consolidated net worth formula starting at $319,115,000, as well as standard events of default.